Similar articles

• Immunohistochemical localization of dopamine- -hydroxylase in the peripheral and central nervous system.

  Fuxe K, Goldstein M, Hökfelt T, Joh TH. Fuxe K, et al. Res Commun Chem Pathol Pharmacol. 1970 Sep;1(5):627-36. Res Commun Chem Pathol Pharmacol. 1970. PMID: 4944550 No abstract available.
• Endogenous inhibitors of dopamine beta-hydroxylase: separation of multiple forms and access to the enzyme.

  Orcutt JC, Molinoff PB. Orcutt JC, et al. J Pharmacol Exp Ther. 1977 Sep;202(3):590-600. J Pharmacol Exp Ther. 1977. PMID: 894523 No abstract available.
• Serum and tissue dopamine-beta-hydroxylase activity in hypophysectomized rats.

  Freedman LS, Roffman M, Goldstein M, Fuxe K, Hökfelt T. Freedman LS, et al. Eur J Pharmacol. 1973 Dec;24(3):366-74. doi: 10.1016/0014-2999(73)90164-7. Eur J Pharmacol. 1973. PMID: 4358314 No abstract available.
• Immunofluorescent localization of dopamine beta-hydroxylase in tissues.

  Hartman BK, Udenfriend S. Hartman BK, et al. Mol Pharmacol. 1970 Jan;6(1):85-94. Mol Pharmacol. 1970. PMID: 4125725 No abstract available.
• Dopamine- -hydroxylase: regulation of its synthesis and release from nerve terminals.

  Axelrod J. Axelrod J. Pharmacol Rev. 1972 Jun;24(2):233-43. Pharmacol Rev. 1972. PMID: 4344260 Review. No abstract available.